-
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
PharmaSources
May 05, 2023
April 12, 2023,ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for IOS-1002.
-
FDA Raises Concerns About China-Developed Drugs
FirstWordPharma
February 10, 2022
A negative FDA staff report for Eli Lilly and partner Innovent Biologics' anti-PD-1 cancer drug sintilimab could slow the plans of large Western drugmakers such as Novartis looking to sell Chinese-tested medicines...
-
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
AmericanPharmaceuticalReview
February 09, 2022
Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.
-
Rural Residents More Fatalistic About Cancer
drugs.com
February 09, 2022
Rural residents show higher levels of cancer fatalism and cancer information overload than urban residents, according to a study published ...
-
cancer patients miss out on innovative new treatments
pharmatimes
February 07, 2022
Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes.
-
Sajid Javid combats cancer crisis
pharmatimes
February 04, 2022
UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease misery.
-
FLIP sync: Collaboration for inhibitors and cancer treatments
pharmatimes
January 26, 2022
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments.
-
Know Your Thyroid Facts
drugs
January 10, 2022
Thyroid cancer diagnoses have spiked for U.S. women this past decade.
-
Protecting People with Cancer from COVID-19: New Recommendations from Cancer Guidelines Organization
prnewswire
January 05, 2022
Today, the National Comprehensive Cancer Network® (NCCN®) published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of COVID-19 in people with cancer.
-
New blood test can identify presence of cancer
pharmatimes
January 05, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.